Brainspark PLC
23 December 2005
FOR IMMEDIATE RELEASE 23 DECEMBER 2005
BRAINSPARK PLC
('Brainspark' or the 'Company')
£850,000 Loan Stock fully subscribed
Option over Infusion 2002 shares effective
The Company is delighted to announce that further to the announcement on 2
December 2005, ('£850,000 Loan Stock'), all subscription monies were received
by the 10 December 2005 deadline, and all funds have been transferred into the
Company.
Mr Francesco Gardin, Chairman, has subsequently transferred Loan Stock to the
value of £50,000 to Mr Dennis Bailey, proposed director. The Company intends
to announce the appointment of Mr Bailey in the near future.
In addition, and further to the announcement on 8 August 2005, the Company
announces that it has agreed pursuant to the agreement signed ('the Call Option
Agreement') to grant a call option (the 'Option') to AISoftware SpA
('AISoftware') over the entire issued share capital of its wholly owned
subsidiary, Infusion 2002 Limited ('Infusion'). The condition that, by the 31
October 2005 Infusion 2002 will have no assets or liabilities other than the
investment in ACS, has been satisfied and formally accepted by AISoftware on 14
December 2005.
ENDS
Further information
Francesco Gardin, Brainspark PLC 020 7843 9838
Roland Cornish, Beaumont Cornish Limited 020 7628 3396
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.